Comie, Roselyn A.
HRN: 23-75-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2024
MUPIROCIN 2%, 15G (TUBE)
12/02/2024
12/09/2024
TOPICAL
2%
Bid
Post Op
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes